Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vesiculopustular dermatosis: an uncommon side-effect of liraglutide?
Besemer F, Verschoor AJ, Diamant M, Hoogma RP. Besemer F, et al. Among authors: hoogma rp. J Diabetes Complications. 2012 Sep-Oct;26(5):458-9. doi: 10.1016/j.jdiacomp.2012.05.018. Epub 2012 Jun 23. J Diabetes Complications. 2012. PMID: 22727533
Cerebral blood flow and glucose metabolism in appetite-related brain regions in type 1 diabetic patients after treatment with insulin detemir and NPH insulin: a randomized controlled crossover trial.
van Golen LW, IJzerman RG, Huisman MC, Hensbergen JF, Hoogma RP, Drent ML, Lammertsma AA, Diamant M. van Golen LW, et al. Among authors: hoogma rp. Diabetes Care. 2013 Dec;36(12):4050-6. doi: 10.2337/dc13-0093. Epub 2013 Oct 15. Diabetes Care. 2013. PMID: 24130356 Free PMC article. Clinical Trial.
Determinants of daily insulin use in Type 1 diabetes.
Muis MJ, Bots ML, Bilo HJ, Hoogma RP, Hoekstra JB, Grobbee DE, Stolk RP. Muis MJ, et al. Among authors: hoogma rp. J Diabetes Complications. 2006 Nov-Dec;20(6):356-60. doi: 10.1016/j.jdiacomp.2005.08.006. J Diabetes Complications. 2006. PMID: 17070438
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.
Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group. Hoogma RP, et al. Diabet Med. 2006 Feb;23(2):141-7. doi: 10.1111/j.1464-5491.2005.01738.x. Diabet Med. 2006. PMID: 16433711 Clinical Trial.
Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.
Janssen MM, Snoek FJ, Masurel N, Hoogma RP, Devillé WL, Popp-Snijders C, Heine RJ. Janssen MM, et al. Among authors: hoogma rp. Diabetes Care. 2000 May;23(5):629-33. doi: 10.2337/diacare.23.5.629. Diabetes Care. 2000. PMID: 10834421 Clinical Trial.
36 results